HealthEquity, Inc.: HealthEquity Reports Second Quarter Ended July 31, 2026 Financial Results
HealthEquity reported Q2 2026 revenue of $350.7M (+8%), net income of $65.6M (+10%), and adjusted EBITDA of $167.0M (+11%). HSA assets grew 14% to $37.9B. The company raised fiscal 2027 guidance and repurchased $108.1M in shares.
How this was made
The 30-second read
Why it matters
Earnings beat and raised guidance likely to drive short‑term buying pressure.
Market read
Strong earnings and guidance upgrade make HQY a notable earnings mover.
What to watch
Potential regulatory changes to HSAs could affect future growth.
Background
HealthEquity is the largest independent HSA custodian, reporting Q2 2026 results and FY 2027 outlook.
Ticker impact
HealthEquity reported Q2 2026 results with revenue up 8% and raised FY 2027 guidance to $1.411‑$1.421B.
Potential price appreciation on earnings beat and raised outlook.
Revenue and earnings beat expectations; guidance increase signals growth, likely to attract buying.
Market effects
Positive for HSA/benefits management sector, may lift peers.
U.S. health‑benefits market sees increased investor interest.
Limited to U.S. listed health‑savings providers.
Counterpoint
Guidance may already be priced in; watch for execution risk.
Key entities
- ExecutiveScott Cutler
President and CEO of HealthEquity, quoted on results.

